|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Metro G, Chiari R, Mare M, et al:
Carboplatin plus pemetrexed for platinum-pretreated, advanced
non-small cell lung cancer: a retrospective study with
pharmacogenetic evaluation. Cancer Chemother Pharmacol.
68:1405–1412. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Siddik ZH: Mechanisms of action of cancer
chemotherapeutic agents: DNA-interactive alkylating agents and
antitumour platinum-based drugs. (The Cancer Handbook). 1st
Edition. Nature Publishing Group; London: pp. 1295–1313. 2002
|
|
5
|
Rosell R, Lord RV, Taron M and Reguart N:
DNA repair and cisplatin resistance in non-small-cell lung cancer.
Lung Cancer. 38:217–227. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bordin DL, Lima M, Lenz G, et al: DNA
alkylation damage and autophagy induction. Mutat Res. 753:91–99.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galluzzi L, Senovilla L, Vitale I, et al:
Molecular mechanisms of cisplatin resistance. Oncogene.
31:1869–1883. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cetintas VB, Kucukaslan AS, Kosova B, et
al: Cisplatin resistance induced by decreased apoptotic activity in
non-small-cell lung cancer cell lines. Cell Biol Int. 36:261–265.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hannigan G, McDonald P, Walsh M and Dedhar
S: Integrin-linked kinase: not so ‘pseudo’after all. Oncogene.
30:4375–4385. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Takanami I: Increased expression of
integrin-linked kinase is associated with shorter survival in
non-small cell lung cancer. BMC Cancer. 5:12005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watzka SB, Rauscher-Pötsch I, Stubenberger
E, et al: Immunoreactivity of integrin-linked kinase in primary
non-small-cell lung cancer and survival after curative resection.
Eur J Cardiothorac Surg. 38:254–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Posch F, Setinek U, Flores RM, et al:
Serum integrin-linked kinase (sILK) concentration and survival in
non-small cell lung cancer: a pilot study. Clin Transl Oncol.
16:455–462. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao M, Gao Y, Wang L, et al:
Overexpression of integrin-linked kinase promotes lung cancer cell
migration and invasion via NF-κB-mediated upregulation of matrix
metalloproteinase-9. Int J Med Sci. 10:995–1002. 2013. View Article : Google Scholar
|
|
14
|
Chen D, Zhang Y, Zhang X, et al:
Overexpression of integrin-linked kinase correlates with malignant
phenotype in non-small cell lung cancer and promotes lung cancer
cell invasion and migration via regulating epithelial-mesenchymal
transition (EMT)-related genes. Acta Histochem. 115:128–136. 2013.
View Article : Google Scholar
|
|
15
|
Gao J, Zhu J, Li HY, Pan XY, Jiang R and
Chen JX: Small interfering RNA targeting integrin-linked kinase
inhibited the growth and induced apoptosis in human bladder cancer
cells. Int J Biochem Cell Biol. 43:1294–1304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu XY, Liu N, Liu W, Song SW and Guo KJ:
Silencing of the integrin-linked kinase gene suppresses the
proliferation, migration and invasion of pancreatic cancer cells
(Panc-1). Genet Mol Biol. 35:538–544. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song W, Jiang R and Zhao CM: Role of
integrin-linked kinase in multi-drug resistance of human gastric
carcinoma SGC7901/DDP cells. Asian Pac J Cancer Prev. 13:5619–5625.
2012. View Article : Google Scholar
|
|
18
|
Younes MN, Yigitbasi OG, Yazici YD, et al:
Effects of the integrin-linked kinase inhibitor QLT0267 on squamous
cell carcinoma of the head and neck. Arch Otolaryngol Head Neck
Surg. 133:152007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dolfen D, Schottler K, Valiahdi SM, et al:
Synthesis, structures and in vitro cytotoxicity of some platinum
(II) complexes containing thiocarbamate esters. J Inorg Biochem.
102:2067–2071. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kalra J, Warburton C, Fang K, et al:
QLT0267, a small molecule inhibitor targeting integrin-linked
kinase (ILK) and docetaxel can combine to produce synergistic
interactions linked to enhanced cytotoxicity, reductions in P-AKT
levels, altered F-actin architecture and improved treatment
outcomes in an orthotopic breast cancer model. Breast Cancer Res.
11:R252009. View
Article : Google Scholar
|
|
21
|
Persad S, Attwell S, Gray V, et al:
Inhibition of integrin-linked kinase (ILK) suppresses activation of
protein kinase B/Akt and induces cell cycle arrest and apoptosis of
PTEN-mutant prostate cancer cells. Proc Natl Acad Sci USA.
97:3207–3212. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Troussard AA, McDonald PC, Wederell ED,
Mawji NM, et al: Preferential dependence of breast cancer cells
versus normal cells on integrin-linked kinase for protein kinase
B/Akt activation and cell survival. Cancer Res. 66:393–403. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin Y, Wang Z, Liu L and Chen L: Akt is
the downstream target of GRP78 in mediating cisplatin resistance in
ER stress-tolerant human lung cancer cells. Lung Cancer.
71:291–297. 2011. View Article : Google Scholar
|
|
24
|
Yang X, Fraser M, Moll UM, Basak A and
Tsang BK: Akt-mediated cisplatin resistance in ovarian cancer:
modulation of p53 action on caspase-dependent mitochondrial death
pathway. Cancer Res. 66:3126–3136. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Peng DJ, Wang J, Zhou JY and Wu GS: Role
of the Akt/mTOR survival pathway in cisplatin resistance in ovarian
cancer cells. Biochem Biophys Res Commun. 394:600–605. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maydan M, McDonald PC, Sanghera J, et al:
Integrin-linked kinase is a functional Mn2+-dependent
protein kinase that regulates glycogen synthase kinase-3β (GSK-3β)
phosphorylation. PloS One. 5:e123562010. View Article : Google Scholar
|
|
27
|
Beurel E and Jope RS: The paradoxical
pro-and anti-apoptotic actions of GSK3 in the intrinsic and
extrinsic apoptosis signaling pathways. Prog Neurobiol. 79:173–189.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Watcharasit P, Thiantanawat A and
Satayavivad J: GSK3 promotes arsenite-induced apoptosis via
facilitation of mitochondria disruption. J Appl Toxicol.
28:466–474. 2008. View
Article : Google Scholar
|
|
29
|
Ngok-Ngam P, Watcharasit P, Thiantanawat A
and Satayavivad J: Pharmacological inhibition of GSK3 attenuates
DNA damage-induced apoptosis via reduction of p53 mitochondrial
translocation and Bax oligomerization in neuroblastoma SH-SY5Y
cells. Cell Mol Biol Lett. 18:58–74. 2013. View Article : Google Scholar
|
|
30
|
Ban JO, Kwak DH, Oh JH, et al: Suppression
of NF-κB and GSK-3β is involved in colon cancer cell growth
inhibition by the PPAR agonist troglitazone. Chem Biol Interact.
188:75–85. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kosacka M, Piesiak P, Kowal A, Gołecki M
and Jankowska R: Galectin-3 and cyclin D1 expression in non-small
cell lung cancer. J Exp Clin Cancer Res. 30:101–107. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li R, An SJ, Chen ZH, et al: Expression of
cyclin D1 splice variants is differentially associated with outcome
in non-small cell lung cancer patients. Hum Pathol. 39:1792–1801.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Huang H, Hu YD, Li N and Zhu Y: Inhibition
of tumor growth and metastasis by non-small cell lung cancer cells
transfected with cyclin D1-targeted siRNA. Oligonucleotides.
19:151–162. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Troussard AA, Costello P, Yoganathan TN,
Kumagai S, Roskelley CD and Dedhar S: The integrin linked kinase
(ILK) induces an invasive phenotype via AP-1 transcription
factor-dependent upregulation of matrix metalloproteinase 9
(MMP-9). Oncogene. 19:5444–5452. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lakka SS, Gondi CS, Yanamandra N, et al:
Inhibition of cathepsin B and MMP-9 gene expression in glioblastoma
cell line via RNA interference reduces tumor cell invasion, tumor
growth and angiogenesis. Oncogene. 23:4681–4689. 2004. View Article : Google Scholar : PubMed/NCBI
|
